Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:56 am Sale | 2021-12-31 | 13G | Exagen Inc. XGN | RTW Investments, LP | 821,414 5.100% | -428,717 (-34.29%) | Filing History |
| 2022-02-14 08:55 am Purchase | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | RTW Investments, LP | 2,863,198 5.600% | 2,863,198 (New Position) | Filing History |
| 2022-02-14 08:53 am Purchase | 2021-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN | RTW Investments, LP | 406,250 6.800% | 406,250 (New Position) | Filing History |
| 2022-02-14 08:51 am Purchase | 2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS | RTW Investments, LP | 2,120,760 6.500% | 2,120,760 (New Position) | Filing History |
| 2022-02-14 08:50 am Purchase | 2021-12-31 | 13G | MacroGenics, Inc. MGNX | RTW Investments, LP | 3,975,554 6.500% | 3,975,554 (New Position) | Filing History |
| 2022-02-14 08:48 am Purchase | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | RTW Investments, LP | 755,482 7.700% | 32,745 (+4.53%) | Filing History |
| 2022-02-14 08:47 am Purchase | 2021-12-31 | 13G | CUTERA INC CUTRQ | RTW Investments, LP | 1,397,063 7.800% | 21,400 (+1.56%) | Filing History |
| 2022-02-14 08:46 am Sale | 2021-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 2,637,192 6.000% | -391,527 (-12.93%) | Filing History |
| 2022-02-14 08:45 am Purchase | 2021-12-31 | 13G | Oyster Point Pharma, Inc. OYST | RTW Investments, LP | 2,058,504 7.900% | 132,910 (+6.90%) | Filing History |
| 2022-02-14 08:44 am Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW Investments, LP | 253,735 6.400% | -10,141 (-3.84%) | Filing History |
| 2022-02-14 08:43 am Purchase | 2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW Investments, LP | 2,186,324 7.900% | 673,651 (+44.53%) | Filing History |
| 2022-02-14 08:43 am Purchase | 2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | RTW Investments, LP | 2,520,076 6.500% | 423,233 (+20.18%) | Filing History |
| 2022-02-14 08:41 am Purchase | 2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | RTW Investments, LP | 3,921,579 8.400% | 498,724 (+14.57%) | Filing History |
| 2022-02-14 08:41 am Sale | 2021-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | RTW Investments, LP | 2,353,015 6.700% | -409,776 (-14.83%) | Filing History |
| 2022-02-14 08:39 am Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW Investments, LP | 2,980,960 6.600% | 2,980,960 (New Position) | Filing History |
| 2022-02-14 08:22 am Purchase | 2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW Investments, LP | 3,866,872 9.500% | 1,795,463 (+86.68%) | Filing History |
| 2022-02-14 08:21 am Purchase | 2021-12-31 | 13G | TELA Bio, Inc. TELA | RTW Investments, LP | 1,399,686 9.700% | 15,870 (+1.15%) | Filing History |
| 2022-02-14 08:20 am Unchanged | 2021-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | RTW Investments, LP | 2,319,138 9.700% | 0 (Unchanged) | Filing History |
| 2022-02-14 08:18 am Sale | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW Investments, LP | 2,013,601 9.700% | -450,000 (-18.27%) | Filing History |
| 2022-02-14 08:16 am Purchase | 2021-12-31 | 13G | BrainsWay Ltd. BWAY | RTW Investments, LP | 3,204,762 9.700% | 997,814 (+45.21%) | Filing History |